- Report
- October 2024
- 193 Pages
Global
From €3245EUR$3,545USD£2,758GBP
€3606EUR$3,939USD£3,064GBP
- Report
- September 2024
- 100 Pages
Global
From €5447EUR$5,950USD£4,629GBP
- Report
- August 2024
- 100 Pages
Global
From €5447EUR$5,950USD£4,629GBP
- Report
- March 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2021
- 420 Pages
United States
From €2197EUR$2,400USD£1,867GBP
- Report
- September 2018
- 174 Pages
Global
From €1259EUR$1,375USD£1,070GBP
€2517EUR$2,750USD£2,139GBP
- Report
- January 2024
- 200 Pages
Global
From €4577EUR$5,000USD£3,890GBP
- Report
- May 2024
- 140 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- April 2024
- 160 Pages
Global
From €4549EUR$4,969USD£3,866GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €458EUR$500USD£389GBP
- Report
- October 2022
- 229 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP

Zyprexa (olanzapine) is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and depression. It is an atypical antipsychotic drug, meaning it works differently than traditional antipsychotics. Zyprexa works by blocking certain receptors in the brain, which helps to reduce symptoms of mental illness. It is available in both oral and injectable forms.
Zyprexa is one of the most commonly prescribed medications for mental disorders. It is used to treat a wide range of mental health conditions, including schizophrenia, bipolar disorder, and depression. It is also used to treat symptoms of anxiety and agitation.
The Zyprexa market is highly competitive, with many companies offering similar products. Some of the major players in the market include Eli Lilly, Pfizer, Novartis, and AstraZeneca. These companies offer a variety of formulations of Zyprexa, including tablets, capsules, and injections. Other companies in the market include Sun Pharmaceuticals, Teva Pharmaceuticals, and Mylan. Show Less Read more